SAN FRANCISCO, Feb. 28 /CNW/ - Patient Home Monitoring (PHM) (TSXV:PHM),
a company focused on in-home cardiology healthcare services, announced
today that it will conduct a conference call and webcast on Tuesday,
March 1, 2011 at 9:00 am ET to review and discuss first quarter 2011
operating results and to provide a corporate update.
About the Conference Call
To listen, please visit the investor website at
PHM is a healthcare services company focused on providing in-home
testing for patients on blood thinner medications such as Coumadin or
warfarin. Medicare recently expanded reimbursement for in-home patient
self testing (PST) of blood coagulation levels. PHM has a unique value
proposition to cardiology groups that manage patients on blood
thinners, focusing on systemization to enroll patients in PST. This
unique, systemized approach creates an opportunity for physician groups
to operate more efficiently, increasing revenue to their clinic while
providing a higher standard of care for patients.
Information in this news release that is not current or historical
factual information may constitute forward-looking information within
the meaning of securities laws. Implicit in this information,
particularly in respect of the future outlook of PHM and anticipated
events or results, are assumptions based on beliefs of PHM's senior
management as well as information currently available to it. While
these assumptions were considered reasonable by PHM at the time of
preparation, they may prove to be incorrect. Readers are cautioned that
actual results are subject to a number of risks and uncertainties,
including the availability of funds and resources to pursue operations,
decline of reimbursement rates, dependence on few payors, possible new
drug discoveries, a novel business model, dependence on key suppliers,
granting of permits and licenses in a highly regulated business,
competition, low profit market segments as well as general economic,
market and business conditions, and could differ materially from what
is currently expected.
THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS STATEMENT.
SOURCE PHM Patient Home Monitoring
For further information:
|Michael Dalsin |
Chairman, Patient Home Monitoring
Managing Director, Stanmore Capital Partners, Inc.
| ||Michael Moore|
416-815-0700 ext. 241